An all-women cohort of biotech founders — habitually under-supported and underfunded in a tech-bro-dominated Bay Area. We back them at the earliest stage: before the science is de-risked, before the term sheets, before the crowd.
Women are the most systematically underfunded group in venture — despite outperforming. Capital flows to pedigree and pattern-matching, not to performance. That gap is the arbitrage FemHaus is built to capture.
~2%
of U.S. venture capital goes to all-women founding teams
12%
of U.S. biotechs over $100M market cap have a female CEO
8%
of biotechs with early raises since late 2023 were women-led
The evidence
Why women are a better investment
The performance data is not close.
+63%
Companies with a female founder outperformed their all-male counterparts over a 10-year period.
+10%
Women-led startups generate 10%+ more cumulative revenue after five years than all-male teams — on less capital.
~2×
Women-owned businesses grew at nearly twice the rate of male-owned businesses between 2019 and 2023.
Higher
Firms with female CEOs and CFOs have shown higher stock performance than those led by men.
The category
Why biotech is the right category
The talent is already there. The leadership and the science are not — yet. That is the entry point.
60%
of the biology workforce is women.
20–30%
hold C-level roles in the field.
$1T
annual global upside from closing the women’s health gap (McKinsey, by 2040).
A structural data gap is a structural opportunity. Women are underrepresented in clinical trials, and there is a lack of research built around female biology. The femtech market alone is growing near 20% a year toward $50B+. Women founders see these problems first — and are best positioned to build the companies that solve them.
The program
What FemHaus is
A high-density, live-in cohort where biotech is the default — dropouts to PhDs, beginners to experts, building alongside each other.
01
Wet lab access
Subsidized bench space at Frontier Tower.
02
Company formation
Incorporation, legal, and banking support.
03
Weekly capital access
VC and founder sessions every week.
04
Live-in community
Residents housed together at the Biopunk House.
05
Conference perks
Discounted access to key industry events.
06
Global intake
International applicants welcome; visa support available.
SF · Nob HillCohort 3 · Sept 15 – Dec 15 2026International welcome
Signature programming
Women Wednesdays
Our weekly ritual — the programming that turns a cohort into a compounding network.
01
Capital hour
A rotating VC or angel takes live office hours with the cohort — real feedback, real intros, real term-sheet momentum.
02
Founder fireside
An operator who has been there shares the unfiltered version: fundraising scars, hiring, the science-to-market leap.
03
Bench-to-pitch demo
Residents show wet-lab progress and pressure-test the pitch with peers before it reaches investors.
04
The table
A shared dinner that closes every Wednesday — where sponsorship, not just mentorship, actually happens.
Traction
Who is already in the room
We care less about pedigree than about people who want to build in biology — but the pedigree is here too.
Founders are raising out of the house, not just building in it.
Three organizations, one cohort
Biopunk Community, The Residency, and Frontier Tower run FemHaus together.
FemHaus · San Francisco
Build with us.
FemHaus concentrates the highest-performing, most underfunded founders in the highest-upside category — and gives them the lab, the capital, and the community to compound. Apply to build here, or partner with us as a sponsor, mentor, or investor.